Sign in

You're signed outSign in or to get full access.

Addus HomeCare (ADUS)

--

Earnings summaries and quarterly performance for Addus HomeCare.

Recent press releases and 8-K filings for ADUS.

Addus HomeCare discusses 2026 operational priorities, growth drivers, and M&A strategy
ADUS
Guidance Update
New Projects/Investments
M&A
  • Addus HomeCare's new President and COO, Heather Dixon, outlined 2026 operational priorities focused on driving census, increasing hours utilization, and community-based initiatives, with the caregiver app rollout in Illinois showing high utilization and planned expansion to New Mexico and Texas.
  • The company anticipates 2%-2.5% volume growth in personal care hours, with Illinois Medicaid redeterminations leading to admissions outpacing discharges, setting up for 2026 census growth. Key rate increases include almost 10% in Texas (effective September 1, 2025) and just under 4% in Illinois (effective January 1, 2026), with optimism for New Mexico in spring 2026.
  • The hospice segment achieved low teens organic revenue growth year-to-date, exceeding the 5%-7% target, driven by leadership changes, business development, and the Bridge program. Addus maintains an annual M&A target of $100 million+ in annualized revenue and is optimistic about increased opportunities in 2026 due to potential rate decreases.
Nov 18, 2025, 3:00 PM
Addus HomeCare Discusses Operational Priorities, Growth Drivers, and M&A Strategy at Stephens 2025 Conference
ADUS
Revenue Acceleration/Inflection
M&A
New Projects/Investments
  • Addus HomeCare is focused on driving census growth and increasing service utilization in personal care through initiatives like a caregiver app being rolled out in key states. The company targets 2%-2.5% volume growth in hours for personal care.
  • Recent reimbursement updates include a nearly 10% increase in Texas (effective September 1, 2025) and just under 4% in Illinois (effective January 1, 2026), with optimism for a potential rate increase in New Mexico in spring 2026.
  • The hospice segment has shown strong performance with year-to-date organic revenue growth in the low teens, exceeding the targeted 5-7%, driven by strategic investments in leadership and business development.
  • Despite high valuations in hospice M&A, Addus maintains an annual target of $100 million in acquired revenue and is well-capitalized to pursue opportunities, especially if market conditions improve in 2026.
  • The company's caregiver base includes 35%-40% family caregivers in states like Illinois and Texas, and it aims to improve its current 83%-83.5% fill rate for authorized hours into the mid-80s.
Nov 18, 2025, 3:00 PM
Addus HomeCare Discusses 2026 Operational Priorities and M&A Strategy
ADUS
M&A
New Projects/Investments
Revenue Acceleration/Inflection
  • Addus HomeCare (ADUS) is focused on driving census growth and hours utilization in 2026, supported by a caregiver app showing high utilization in Illinois and planned expansion to New Mexico and Texas.
  • The company anticipates census growth in 2026 in Illinois as Medicaid redeterminations conclude, with admissions now exceeding discharges. New Mexico has already experienced over 3% growth in recent quarters post-redetermination.
  • Addus targets $100 million in annualized acquired revenue annually, despite high hospice valuations, by focusing on mixed assets. The company is well-capitalized and expects more M&A opportunities in 2026 if interest rates decrease.
  • With current EBITDA margins around 12%, Addus expects top-line growth to enhance G&A leverage, contributing to further EBITDA percentage growth. Technology investments, including the integration of Gentiva onto a single EMR system by late 2026, are key to efficiency.
  • The personal care fill rate is approximately 83%-83.5%, with a goal to reach the mid-80s, highlighting the ongoing focus on caregiver supply and securing state rate increases to support wages.
Nov 18, 2025, 3:00 PM
Addus HomeCare Discusses Growth Strategy and 2026 Outlook
ADUS
M&A
Guidance Update
Hiring
  • Addus HomeCare targets 10% annual revenue growth, with approximately half from organic growth (3-5%) and half from M&A. The company anticipates Personal Care organic growth at the high end or above the 3-5% range through mid-2026, driven by rate increases in Texas and Illinois, and strong hiring trends with 113 hires per business day in Q3 2024.
  • Hospice organic revenue growth is projected at mid to upper single digits longer term, with current strong discharge growth (19% in Q3 2024) expected to moderate by mid-2026.
  • The company prioritizes M&A, aiming for $100 million+ in acquired revenue annually, supported by a strong balance sheet with leverage just under one time. Personal Care acquisitions typically range from 4-8x EBITDA, while hospice deals are more expensive at mid to upper teens EBITDA multiples.
  • The Home Health segment, which is less than 10% of the business, is primarily complementary, and a worst-case 6.4% rate cut could result in an approximate $3 million impact.
  • Addus expects operating income to grow faster than revenue, aiming for G&A as a percentage of revenue to be below 20%, with $1 million in annual savings from Geneva EMR integration in 2026.
Nov 12, 2025, 3:15 PM
Equasens announces Q3 2025 revenue
ADUS
Earnings
Guidance Update
Revenue Acceleration/Inflection
  • Equasens Group reported total revenue of €172.2m for the nine months ended September 30, 2025, representing an 8.9% increase on a reported basis and 7.3% like-for-like growth compared to the same period in 2024.
  • For Q3 2025, revenue reached €56.2m, showing a 12.1% increase on a reported basis and a strong 9.4% like-for-like growth.
  • Systems and equipment sales were a significant growth driver, contributing €8.0m (+13.1%) to the nine-month revenue and €3.8m (+20.7%) in Q3.
  • The PHARMAGEST Division maintained strong momentum, with revenue of €126.6m at 30 September 2025 (+5.4%) and €40.7m in Q3 (+7.1%).
  • The Group maintains its guidance for revenue growth of nearly 10% on a reported basis in the second half of 2025.
Nov 5, 2025, 5:00 PM
IFF Reports Third Quarter 2025 Results and Reaffirms Full Year Guidance
ADUS
Earnings
Guidance Update
Financial Restatement
  • IFF reported Third Quarter 2025 consolidated sales of $2.7 billion and Adjusted EPS excluding amortization of $1.05.
  • For the first nine months of 2025, consolidated sales were $8.3 billion, with a net loss attributable to IFF shareholders of $(392) million.
  • The company reaffirmed its full year 2025 financial guidance, expecting sales in the range of $10.6 billion to $10.9 billion and adjusted operating EBITDA between $2 billion and $2.15 billion.
  • Management identified income tax-related adjustments and will revise previously issued consolidated financial statements for the three and nine months ended September 30, 2024, to correct for these errors.
Nov 4, 2025, 9:15 PM
ADUS Reports Strong Q3 2025 Financial and Operational Growth
ADUS
Earnings
Revenue Acceleration/Inflection
M&A
  • ADUS reported robust financial performance for Q3 2025, with total revenue increasing 25% to $362.3 million compared to Q3 2024, and adjusted earnings per share rising 20% to $1.56. Adjusted EBITDA grew 31.6% to $45.1 million.
  • The company demonstrated strong organic growth, with Personal Care same store revenue increasing 6.6% and Hospice same store revenue growing 19% year-over-year. Hiring performance was also strong, with 113 hires per business day in Q3 2025.
  • ADUS continued its acquisition strategy, closing the acquisition of Del Cielo Home Care Services' personal care operations on October 1, 2025, which is expected to add approximately $12.7 million in annualized revenue. This follows the Gentiva acquisition in December 2024 and Helping Hands in August 2025.
  • The company benefited from significant rate increases, including a 9.9% personal care rate increase in Texas effective September 1, 2025, and an additional 3.9% increase in Illinois effective January 1, 2026. Hospice rates are also expected to increase by 3.1% effective October 1, 2025.
Nov 4, 2025, 2:00 PM
Addus Reports Strong Q3 2025 Financial Performance and Strategic Acquisitions
ADUS
Earnings
M&A
Revenue Acceleration/Inflection
  • ADUS reported Q3 2025 total revenue of $362.3 million, a 25% increase from Q3 2024, with adjusted earnings per share of $1.56, up 20%.
  • Adjusted EBITDA for Q3 2025 increased 31.6% to $45.1 million, achieving an adjusted EBITDA margin of 12.5%.
  • The company strengthened its market presence through acquisitions, including the personal care operations of Del Cielo HomeCare Services (closed October 1, 2025, adding $12.7 million annualized revenue) and Helping Hands HomeCare Services (acquired August 1, 2025, adding $16.7 million annualized revenue).
  • ADUS anticipates positive impacts from rate increases, such as a 9.9% increase in Texas (effective September 1, 2025, adding $17.7 million annualized revenue) and an additional 3.9% increase in Illinois (effective January 1, 2026, adding $17.5 million annualized revenue).
  • Personal care same-store revenue grew 6.6% and hospice same-store revenue increased 19% in Q3 2025, while home health same-store revenue decreased 2.8%.
Nov 4, 2025, 2:00 PM
Addus HomeCare Announces Third Quarter 2025 Financial Results
ADUS
Earnings
M&A
Revenue Acceleration/Inflection
  • Addus HomeCare Corporation reported net service revenues of $362.3 million for the third quarter of 2025, representing a 25.0% increase compared to the same period in 2024.
  • Net income for Q3 2025 was $22.8 million, or $1.24 per diluted share, while adjusted net income per diluted share increased 20.0% year-over-year to $1.56.
  • Adjusted EBITDA for the third quarter of 2025 increased 31.6% year-over-year to $45.1 million.
  • The company completed the acquisition of Del Cielo Home Care Services' personal care operations on October 1, 2025, for $7.4 million, which is expected to contribute approximately $12.5 million in annualized revenues.
  • The personal care business segment accounted for 76.1% of revenues in Q3 2025 and achieved 6.6% organic revenue growth.
Nov 3, 2025, 9:36 PM
Addus HomeCare Announces Third Quarter 2025 Financial Results
ADUS
Earnings
M&A
Revenue Acceleration/Inflection
  • Addus HomeCare reported net service revenues of $362.3 million for the third quarter of 2025, marking a 25.0% increase compared to the prior year. Adjusted net income per diluted share increased 20.0% to $1.56, and Adjusted EBITDA grew 31.6% to $45.1 million year-over-year.
  • The company completed the acquisition of the personal care operations of Del Cielo Home Care Services on October 1, 2025, for $7.4 million, which is expected to expand its personal care coverage in Texas.
  • Cash flow from operations was $51.3 million for the third quarter of 2025, contributing to debt reduction and capital allocation flexibility.
  • The personal care business was the primary driver of growth, accounting for 76.1% of revenues and achieving 6.6% organic revenue growth in Q3 2025.
Nov 3, 2025, 9:05 PM